img

Global Human Albumin Injection Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Albumin Injection Market Research Report 2024

Human albumin solutions are used in a range of medical and surgical problems.
According to Mr Accuracy reports’s new survey, global Human Albumin Injection market is projected to reach US$ 549.4 million in 2029, increasing from US$ 396 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Albumin Injection market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Albumin Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals
Segment by Type
Blood Extraction
Recombine

Segment by Application


Hospital
Clinic

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Albumin Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Human Albumin Injection Market Overview
1.1 Product Overview and Scope of Human Albumin Injection
1.2 Human Albumin Injection Segment by Type
1.2.1 Global Human Albumin Injection Market Value Comparison by Type (2024-2034)
1.2.2 Blood Extraction
1.2.3 Recombine
1.3 Human Albumin Injection Segment by Application
1.3.1 Global Human Albumin Injection Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Human Albumin Injection Market Size Estimates and Forecasts
1.4.1 Global Human Albumin Injection Revenue 2018-2029
1.4.2 Global Human Albumin Injection Sales 2018-2029
1.4.3 Global Human Albumin Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Albumin Injection Market Competition by Manufacturers
2.1 Global Human Albumin Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Human Albumin Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Human Albumin Injection Average Price by Manufacturers (2018-2024)
2.4 Global Human Albumin Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Human Albumin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Albumin Injection, Product Type & Application
2.7 Human Albumin Injection Market Competitive Situation and Trends
2.7.1 Human Albumin Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Albumin Injection Players Market Share by Revenue
2.7.3 Global Human Albumin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Albumin Injection Retrospective Market Scenario by Region
3.1 Global Human Albumin Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Albumin Injection Global Human Albumin Injection Sales by Region: 2018-2029
3.2.1 Global Human Albumin Injection Sales by Region: 2018-2024
3.2.2 Global Human Albumin Injection Sales by Region: 2024-2029
3.3 Global Human Albumin Injection Global Human Albumin Injection Revenue by Region: 2018-2029
3.3.1 Global Human Albumin Injection Revenue by Region: 2018-2024
3.3.2 Global Human Albumin Injection Revenue by Region: 2024-2029
3.4 North America Human Albumin Injection Market Facts & Figures by Country
3.4.1 North America Human Albumin Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Albumin Injection Sales by Country (2018-2029)
3.4.3 North America Human Albumin Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Albumin Injection Market Facts & Figures by Country
3.5.1 Europe Human Albumin Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Albumin Injection Sales by Country (2018-2029)
3.5.3 Europe Human Albumin Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Albumin Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Human Albumin Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Albumin Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Albumin Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Albumin Injection Market Facts & Figures by Country
3.7.1 Latin America Human Albumin Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Albumin Injection Sales by Country (2018-2029)
3.7.3 Latin America Human Albumin Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Albumin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Albumin Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Albumin Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Albumin Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Albumin Injection Sales by Type (2018-2029)
4.1.1 Global Human Albumin Injection Sales by Type (2018-2024)
4.1.2 Global Human Albumin Injection Sales by Type (2024-2029)
4.1.3 Global Human Albumin Injection Sales Market Share by Type (2018-2029)
4.2 Global Human Albumin Injection Revenue by Type (2018-2029)
4.2.1 Global Human Albumin Injection Revenue by Type (2018-2024)
4.2.2 Global Human Albumin Injection Revenue by Type (2024-2029)
4.2.3 Global Human Albumin Injection Revenue Market Share by Type (2018-2029)
4.3 Global Human Albumin Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Albumin Injection Sales by Application (2018-2029)
5.1.1 Global Human Albumin Injection Sales by Application (2018-2024)
5.1.2 Global Human Albumin Injection Sales by Application (2024-2029)
5.1.3 Global Human Albumin Injection Sales Market Share by Application (2018-2029)
5.2 Global Human Albumin Injection Revenue by Application (2018-2029)
5.2.1 Global Human Albumin Injection Revenue by Application (2018-2024)
5.2.2 Global Human Albumin Injection Revenue by Application (2024-2029)
5.2.3 Global Human Albumin Injection Revenue Market Share by Application (2018-2029)
5.3 Global Human Albumin Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Octapharma
6.1.1 Octapharma Corporation Information
6.1.2 Octapharma Description and Business Overview
6.1.3 Octapharma Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Octapharma Human Albumin Injection Product Portfolio
6.1.5 Octapharma Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Behring Human Albumin Injection Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Biotest (UK) Ltd
6.3.1 Biotest (UK) Ltd Corporation Information
6.3.2 Biotest (UK) Ltd Description and Business Overview
6.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Biotest (UK) Ltd Human Albumin Injection Product Portfolio
6.3.5 Biotest (UK) Ltd Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Baxter Human Albumin Injection Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Kedrion Biopharma, Inc.
6.5.1 Kedrion Biopharma, Inc. Corporation Information
6.5.2 Kedrion Biopharma, Inc. Description and Business Overview
6.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio
6.5.5 Kedrion Biopharma, Inc. Recent Developments/Updates
6.6 Grifols
6.6.1 Grifols Corporation Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Grifols Human Albumin Injection Product Portfolio
6.6.5 Grifols Recent Developments/Updates
6.7 GE HealthCare
6.6.1 GE HealthCare Corporation Information
6.6.2 GE HealthCare Description and Business Overview
6.6.3 GE HealthCare Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GE HealthCare Human Albumin Injection Product Portfolio
6.7.5 GE HealthCare Recent Developments/Updates
6.8 Bio Products Laboratory
6.8.1 Bio Products Laboratory Corporation Information
6.8.2 Bio Products Laboratory Description and Business Overview
6.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bio Products Laboratory Human Albumin Injection Product Portfolio
6.8.5 Bio Products Laboratory Recent Developments/Updates
6.9 Green Cross
6.9.1 Green Cross Corporation Information
6.9.2 Green Cross Description and Business Overview
6.9.3 Green Cross Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Green Cross Human Albumin Injection Product Portfolio
6.9.5 Green Cross Recent Developments/Updates
6.10 SK Plasma
6.10.1 SK Plasma Corporation Information
6.10.2 SK Plasma Description and Business Overview
6.10.3 SK Plasma Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.10.4 SK Plasma Human Albumin Injection Product Portfolio
6.10.5 SK Plasma Recent Developments/Updates
6.11 Instituto Grifols
6.11.1 Instituto Grifols Corporation Information
6.11.2 Instituto Grifols Human Albumin Injection Description and Business Overview
6.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Instituto Grifols Human Albumin Injection Product Portfolio
6.11.5 Instituto Grifols Recent Developments/Updates
6.12 Takeda
6.12.1 Takeda Corporation Information
6.12.2 Takeda Human Albumin Injection Description and Business Overview
6.12.3 Takeda Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Takeda Human Albumin Injection Product Portfolio
6.12.5 Takeda Recent Developments/Updates
6.13 Hualan Bio
6.13.1 Hualan Bio Corporation Information
6.13.2 Hualan Bio Human Albumin Injection Description and Business Overview
6.13.3 Hualan Bio Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Hualan Bio Human Albumin Injection Product Portfolio
6.13.5 Hualan Bio Recent Developments/Updates
6.14 Nanyue Biopharmaceuticals
6.14.1 Nanyue Biopharmaceuticals Corporation Information
6.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Description and Business Overview
6.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio
6.14.5 Nanyue Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Albumin Injection Industry Chain Analysis
7.2 Human Albumin Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Albumin Injection Production Mode & Process
7.4 Human Albumin Injection Sales and Marketing
7.4.1 Human Albumin Injection Sales Channels
7.4.2 Human Albumin Injection Distributors
7.5 Human Albumin Injection Customers
8 Human Albumin Injection Market Dynamics
8.1 Human Albumin Injection Industry Trends
8.2 Human Albumin Injection Market Drivers
8.3 Human Albumin Injection Market Challenges
8.4 Human Albumin Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Albumin Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Human Albumin Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Human Albumin Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Albumin Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Human Albumin Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Human Albumin Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Human Albumin Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Human Albumin Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Human Albumin Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Human Albumin Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Albumin Injection, Product Type & Application
Table 12. Global Key Manufacturers of Human Albumin Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Albumin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Albumin Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Albumin Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Albumin Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Human Albumin Injection Sales Market Share by Region (2018-2024)
Table 19. Global Human Albumin Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Albumin Injection Sales Market Share by Region (2024-2029)
Table 21. Global Human Albumin Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Human Albumin Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Human Albumin Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Albumin Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Albumin Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Albumin Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Human Albumin Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Albumin Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Human Albumin Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Albumin Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Albumin Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Human Albumin Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Albumin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Human Albumin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Albumin Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Human Albumin Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Human Albumin Injection Sales Market Share by Type (2018-2024)
Table 53. Global Human Albumin Injection Sales Market Share by Type (2024-2029)
Table 54. Global Human Albumin Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Human Albumin Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Albumin Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Human Albumin Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Human Albumin Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Human Albumin Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Albumin Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Human Albumin Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Human Albumin Injection Sales Market Share by Application (2018-2024)
Table 63. Global Human Albumin Injection Sales Market Share by Application (2024-2029)
Table 64. Global Human Albumin Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Human Albumin Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Albumin Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Human Albumin Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Human Albumin Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Human Albumin Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Octapharma Corporation Information
Table 71. Octapharma Description and Business Overview
Table 72. Octapharma Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Octapharma Human Albumin Injection Product
Table 74. Octapharma Recent Developments/Updates
Table 75. CSL Behring Corporation Information
Table 76. CSL Behring Description and Business Overview
Table 77. CSL Behring Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. CSL Behring Human Albumin Injection Product
Table 79. CSL Behring Recent Developments/Updates
Table 80. Biotest (UK) Ltd Corporation Information
Table 81. Biotest (UK) Ltd Description and Business Overview
Table 82. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Biotest (UK) Ltd Human Albumin Injection Product
Table 84. Biotest (UK) Ltd Recent Developments/Updates
Table 85. Baxter Corporation Information
Table 86. Baxter Description and Business Overview
Table 87. Baxter Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Baxter Human Albumin Injection Product
Table 89. Baxter Recent Developments/Updates
Table 90. Kedrion Biopharma, Inc. Corporation Information
Table 91. Kedrion Biopharma, Inc. Description and Business Overview
Table 92. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Kedrion Biopharma, Inc. Human Albumin Injection Product
Table 94. Kedrion Biopharma, Inc. Recent Developments/Updates
Table 95. Grifols Corporation Information
Table 96. Grifols Description and Business Overview
Table 97. Grifols Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Grifols Human Albumin Injection Product
Table 99. Grifols Recent Developments/Updates
Table 100. GE HealthCare Corporation Information
Table 101. GE HealthCare Description and Business Overview
Table 102. GE HealthCare Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. GE HealthCare Human Albumin Injection Product
Table 104. GE HealthCare Recent Developments/Updates
Table 105. Bio Products Laboratory Corporation Information
Table 106. Bio Products Laboratory Description and Business Overview
Table 107. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bio Products Laboratory Human Albumin Injection Product
Table 109. Bio Products Laboratory Recent Developments/Updates
Table 110. Green Cross Corporation Information
Table 111. Green Cross Description and Business Overview
Table 112. Green Cross Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Green Cross Human Albumin Injection Product
Table 114. Green Cross Recent Developments/Updates
Table 115. SK Plasma Corporation Information
Table 116. SK Plasma Description and Business Overview
Table 117. SK Plasma Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. SK Plasma Human Albumin Injection Product
Table 119. SK Plasma Recent Developments/Updates
Table 120. Instituto Grifols Corporation Information
Table 121. Instituto Grifols Description and Business Overview
Table 122. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Instituto Grifols Human Albumin Injection Product
Table 124. Instituto Grifols Recent Developments/Updates
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Takeda Human Albumin Injection Product
Table 129. Takeda Recent Developments/Updates
Table 130. Hualan Bio Corporation Information
Table 131. Hualan Bio Description and Business Overview
Table 132. Hualan Bio Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Hualan Bio Human Albumin Injection Product
Table 134. Hualan Bio Recent Developments/Updates
Table 135. Nanyue Biopharmaceuticals Corporation Information
Table 136. Nanyue Biopharmaceuticals Description and Business Overview
Table 137. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Nanyue Biopharmaceuticals Human Albumin Injection Product
Table 139. Nanyue Biopharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Human Albumin Injection Distributors List
Table 143. Human Albumin Injection Customers List
Table 144. Human Albumin Injection Market Trends
Table 145. Human Albumin Injection Market Drivers
Table 146. Human Albumin Injection Market Challenges
Table 147. Human Albumin Injection Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Albumin Injection
Figure 2. Global Human Albumin Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Human Albumin Injection Market Share by Type in 2022 & 2029
Figure 4. Blood Extraction Product Picture
Figure 5. Recombine Product Picture
Figure 6. Global Human Albumin Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Human Albumin Injection Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Human Albumin Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Human Albumin Injection Market Size (2018-2029) & (US$ Million)
Figure 12. Global Human Albumin Injection Sales (2018-2029) & (K Units)
Figure 13. Global Human Albumin Injection Average Price (US$/Unit) & (2018-2029)
Figure 14. Human Albumin Injection Report Years Considered
Figure 15. Human Albumin Injection Sales Share by Manufacturers in 2022
Figure 16. Global Human Albumin Injection Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Human Albumin Injection Players: Market Share by Revenue in 2022
Figure 18. Human Albumin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Human Albumin Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Human Albumin Injection Sales Market Share by Country (2018-2029)
Figure 21. North America Human Albumin Injection Revenue Market Share by Country (2018-2029)
Figure 22. United States Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Human Albumin Injection Sales Market Share by Country (2018-2029)
Figure 25. Europe Human Albumin Injection Revenue Market Share by Country (2018-2029)
Figure 26. Germany Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Human Albumin Injection Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Human Albumin Injection Revenue Market Share by Region (2018-2029)
Figure 33. China Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Human Albumin Injection Sales Market Share by Country (2018-2029)
Figure 41. Latin America Human Albumin Injection Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Human Albumin Injection Sales Market Share by Country (2018-2029)
Figure 46. Middle East & Africa Human Albumin Injection Revenue Market Share by Country (2018-2029)
Figure 47. Turkey Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. UAE Human Albumin Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Global Sales Market Share of Human Albumin Injection by Type (2018-2029)
Figure 51. Global Revenue Market Share of Human Albumin Injection by Type (2018-2029)
Figure 52. Global Human Albumin Injection Price (US$/Unit) by Type (2018-2029)
Figure 53. Global Sales Market Share of Human Albumin Injection by Application (2018-2029)
Figure 54. Global Revenue Market Share of Human Albumin Injection by Application (2018-2029)
Figure 55. Global Human Albumin Injection Price (US$/Unit) by Application (2018-2029)
Figure 56. Human Albumin Injection Value Chain
Figure 57. Human Albumin Injection Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries